The advertisement promotes BENLYSTA (belimumab) as a treatment that reduces disease activity related to lupus and protects kidneys, while also providing important safety information regarding potential allergic reactions and infections.
Creative Information
| CID: | 9f107782-57b0-4b20-a543-141b6a558b08 |
| CRID: | 82_6929-803175 |
| Domain: | benlysta.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $14.11 |
| Timestamp: | 10/31/2025, 1:25:53 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 2:34:03 AM | 6.26s | |
| adomain_analysis | success | 10/31/2025, 5:20:30 AM | 3.66s | |
| adomain_capture | success | 10/31/2025, 5:20:26 AM | 0.10s | |
| ad_render | success | 10/31/2025, 2:33:56 AM | 24.88s | |
| brand_mapping | success | 10/31/2025, 1:25:53 AM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: Benlysta
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1895.98 KB | ||||||||||||||||||||||
| Render Time: | 9.15 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1927.83 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

